Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters
BioSpace
Fri, 11/2/18 - 07:59 pm
Tags:
AbbVie, San Francisco, biotech clusters, Bay Area
AbbVie says global Humira market eroding faster than expected
BioCentury
Fri, 11/2/18 - 07:55 pm
Tags:
AbbVie, Humira
AbbVie lifts profit target after cancer drug powers quarterly beat
Yahoo/Reuters
Fri, 11/2/18 - 09:26 am
Tags:
AbbVie, earnings
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Tags:
Roche, Genentech, AbbVie, clinical trials, Venclexta, Gazyva, CLL, chronic lymphocytic leukemia
Novartis wins US nod for Humira biosimilar, but focus now on Europe
Biopharma Dive
Wed, 10/31/18 - 07:09 pm
Tags:
Novartis, Hyrimoz, biosimilars, Humira, AbbVie, FDA
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics, Allergan, Pfizer, Clovis Oncology, Acorda Therapeutics, Takeda, Agios Pharmaceuticals, Shire, Teva Pharmaceutical, AbbVie
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
Motley Fool
Sat, 10/27/18 - 11:55 am
Tags:
AbbVie, Vertex Pharmaceuticals, cystic fibrosis
Abbott, AbbVie settle TriCor marketing case for $25 million
Yahoo/Reuters
Sat, 10/27/18 - 11:38 am
Tags:
Abbott Labs, AbbVie, kickbacks, TriCor
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
Fri, 10/26/18 - 09:54 am
Tags:
NICE, AbbVie, Venclyxto, Roche, Rituxan/MabThera, CLL
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
BioSpace
Thu, 10/25/18 - 11:35 am
Tags:
AbbVie, Galapagos, cystic fibrosis
AbbVie rheumatoid arthritis drug succeeds in late stage trial
Yahoo/Reuters
Tue, 10/23/18 - 10:40 am
Tags:
AbbVie, clinical trials, rheumatoid arthritis, Upadacitinib
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Tags:
Europe, AbbVie, Humira, Amgen, Samsung Bioepis, Mylan Labs, Novartis, Sandoz, Fresenius Kabi, Boehringer Ingelheim
AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring
Fierce Pharma
Fri, 10/19/18 - 11:13 pm
Tags:
AbbVie, Abbott, Imbruvica
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
Fierce Pharma
Thu, 10/18/18 - 11:29 pm
Tags:
Humira, AbbVie, Fresenius Kabi, Europe
AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance
Xconomy
Thu, 10/18/18 - 11:24 am
Tags:
AbbVie, Morphic Therapeutics, R&D, fibrosis
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
Wed, 10/17/18 - 12:24 pm
Tags:
AbbVie, FDA, priority review, Imbruvica, Gazyva, CLL, SLL
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Wed, 10/17/18 - 09:09 am
Tags:
Donald Trump, drug ads, drug pricing, Pfizer, AbbVie, Eli Lilly, Amgen, Allergan
7 drugmakers to watch during Q3 earnings
Biopharma Dive
Mon, 10/15/18 - 12:31 pm
Tags:
earnings, Novartis, Gilead Sciences, Amgen, Pfizer, GSK, AbbVie, Regeneron
Pharma TV buys so far top last year's $1B spend; AbbVie, Pfizer lead September
Fierce Pharma
Mon, 10/15/18 - 12:12 pm
Tags:
drug ads, television ads, AbbVie, Pfizer
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Tags:
Novartis, Sandoz, AbbVie, Humira, biosimilars, Europe

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.